Abstract:
N-Terminal proeB-type natriuretic peptide (NT-proBNP) is a useful test to “rule out” heart failure (HF) in patients presenting with dyspnea in primary care. However, many false positive diagnoses may occur. Early identification of abnormal left ventricular (LV) function would allow early intervention. The aim of this study was to predict LV dysfunction in these patients using a combination of neurohormones and other clinical factors.